Medicare Enrolled
Dr. Amiel Tokayer, M.D.
Rheumatology · Boynton Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tokayer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tokayer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tokayer
Dr. Amiel Tokayer is a rheumatology specialist in Boynton Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tokayer performed 219,394 Medicare services across 3,840 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tokayer received a total of $62,188 from 54 pharmaceutical and/or device companies across 1407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tokayer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in FL
$62,188 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 83054 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗219,394
Medicare services
Top 8% in FL for rheumatology
3,840
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,970 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 61,162 | $5 | $9 |
| Romosozumab injection (Evenity) for osteoporosis | 42,848 | $8 | $13 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
41,400 | $4 | $14 |
| Denosumab injection (Prolia/Xgeva) | 39,362 | $18 | $28 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
10,800 | $34 | $62 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
8,650 | $11 | $35 |
| Joint lubricant injection (GenVisc) An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
4,200 | $5 | $20 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
2,150 | $26 | $57 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
1,750 | $64 | $110 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
1,077 | $59 | $95 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,048 | $97 | $155 |
| Injection, methylprednisolone acetate, 40 mg | 985 | $6 | $10 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
636 | $1 | $5 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
551 | $44 | $109 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
431 | $69 | $110 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
403 | $106 | $200 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
221 | $6 | $20 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
212 | $35 | $84 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
201 | $29 | $83 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
173 | $125 | $210 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
133 | $5 | $10 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
120 | $26 | $67 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
109 | $37 | $105 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
100 | $23 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
68 | $138 | $225 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
65 | $29 | $68 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
58 | $46 | $95 |
| New patient office visit, complex (60-74 min) | 51 | $162 | $267 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
45 | $48 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
45 | $11 | $35 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
44 | $31 | $60 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
38 | $26 | $65 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
35 | $13 | $45 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
33 | $35 | $90 |
| Lower back and sciatic nerve injection An injection of an anesthetic and/or steroid medication into the lower back and sciatic nerve. This procedure delivers medication directly to the nerve site. |
29 | $129 | $245 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
27 | $4 | $10 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
26 | $8 | $150 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
25 | $34 | $61 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
24 | $81 | $150 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
19 | $38 | $90 |
| Injection of carpal tunnel | 15 | $64 | $175 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
13 | $21 | $58 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
12 | $25 | $68 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.0% high complexity
89.0% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$62,188
Total received (2018-2024)
Avg $8,884/year across 7 years
Top 11% in FL for rheumatology
54
Companies
1,407
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$36,350 (58.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,136 (37.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,701 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,413
2023
$4,467
2022
$3,804
2021
$5,520
2020
$18,299
2019
$13,660
2018
$11,025
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
United Rheumatology
$36,250
Horizon Therapeutics plc
$3,247
Amgen Inc.
$2,775
Janssen Biotech, Inc.
$2,768
UCB, Inc.
$2,100
Novartis Pharmaceuticals Corporation
$1,818
PFIZER INC.
$1,400
AbbVie Inc.
$1,293
GlaxoSmithKline, LLC.
$1,207
ABBVIE INC.
$1,162
Radius Health, Inc.
$1,087
E.R. Squibb & Sons, L.L.C.
$1,017
Lilly USA, LLC
$750
ANI Pharmaceuticals, Inc.
$709
Genentech USA, Inc.
$689
AbbVie, Inc.
$636
AstraZeneca Pharmaceuticals LP
$599
Celgene Corporation
$219
GENZYME CORPORATION
$174
Actelion Pharmaceuticals US, Inc.
$157
Janssen Scientific Affairs, LLC
$125
Aurinia Pharma U.S., Inc.
$124
Fresenius Kabi USA, LLC
$121
SANOFI-AVENTIS U.S. LLC
$113
Genentech, Inc.
$110
Mallinckrodt LLC
$108
Insulet Corporation
$108
Sobi, Inc
$107
Alexion Pharmaceuticals, Inc.
$104
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
Cardinal Health 110 LLC
$100
Johnson & Johnson Health Care Systems Inc.
$94
Horizon Pharma plc
$77
Kyowa Kirin, Inc.
$76
Antares Pharma, Inc.
$70
Alvogen Inc
$64
Mallinckrodt Hospital Products Inc.
$58
SOBI, INC
$57
FIDIA PHARMA USA INC.
$46
Ferring Pharmaceuticals Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$39
Kiniksa Pharmaceuticals International, plc
$35
Novo Nordisk Inc
$34
Smith+Nephew, Inc.
$33
Organon LLC
$32
Ultragenyx Pharmaceutical Inc.
$25
Fidia Pharma USA Inc.
$23
Kiniksa Pharmaceuticals, Ltd.
$19
DePuy Synthes Sales Inc.
$16
Kowa Pharmaceuticals America, Inc.
$15
MEDEXUS PHARMA, INC.
$15
Hikma Pharmaceuticals USA
$14
Regeneron Healthcare Solutions, Inc.
$13
Purdue Pharma L.P.
$12
Top 3 companies account for 68.0% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · Cimzia · Crysvita · EUFLEXXA · EVENITY · Enbrel · FORTEO · Fintepla · HADLIMA · HUMIRA · HYALGAN · HYMOVIS · HYQVIA · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NOCDURNA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · ORTHOVISC · Omnipod · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REAL INTELLIGENCE · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYMPROIC · SYNVISC-ONE · Seglentis · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tymlos · Wegovy · XELJANZ · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (58%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $28 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
63
Per 100K population
4.2
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tokayer is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), with consulting-driven industry engagement in the top 11% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tokayer experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Tokayer performed 61,162 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tokayer receive payments from pharmaceutical companies?
Yes. Dr. Tokayer received a total of $62,188 from 54 companies across 1,407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tokayer's costs compare to other rheumatologists in Boynton Beach?
Dr. Tokayer's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tokayer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Boynton Beach
Browse rheumatologists in Boynton Beach ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
United Rheumatology Payments to Doctors
See all physicians who received payments from United Rheumatology.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology